![Justin Klee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 51 M $ al 31/05/2026
Justin Klee is the founder of Amylyx Pharmaceuticals, Inc., founded in 2013, and holds the title of Co-Chief Executive Officer & Executive Director since 2014.
Former job includes Member at Harvard Medical School.
Education includes undergraduate degree from Brown University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 10/04/2026 | 3.583.481 ( 3,22 % ) | 51 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| AMYLYX PHARMACEUTICALS, INC. | Fundador | 01/01/2013 |
| Empresas | Cargo | Fin |
|---|---|---|
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amylyx Pharmaceuticals, Inc.
 Amylyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products to cure neurodegenerative diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
